<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                   FORM 10-QSB

                Quarterly report under Section 13 or 15(d) of the
                        Securities Exchange Act of 1934

                For the quarterly period ended September 30, 1998
                         Commission file number 0-15148

                         ------------------------------

                          SCIENTIFIC NRG, INCORPORATED
             (Exact name of registrant as specified in its charter)

                                    Minnesota
         (State or Other Jurisdiction of Incorporation or Organization)

                                2246 Lindsay Way
                           Glendora, California 91740
                    (Address of Principal Executive Offices)

                                   41-1457271
                      (I.R.S. Employer Identification No.)


       Registrant's telephone number, including area code: (909) 305-0322

                         ------------------------------

        Check whether the issuer (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. Yes  X   No
                                                                       ---

        State the number of shares outstanding of each of the issuer's classes
of common equity, as of the latest practicable date. At November 4, 1998 the
registrant had 5,586,163 shares of common stock, no par value, issued and
outstanding.


<PAGE>   2



                                TABLE OF CONTENTS

                                                                           PAGE
                                     PART I

ITEM 1.  FINANCIAL STATEMENTS.                                               3

ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS.                               3

                                     PART II

ITEM 1.  LEGAL PROCEEDINGS.                                                 11

ITEM 2.  CHANGES IN SECURITIES.                                             11

ITEM 3.  DEFAULT UPON SENIOR SECURITIES.                                    11

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY-HOLDERS.               11

ITEM 5.  OTHER INFORMATION.                                                 11

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K.                                  11


<PAGE>   3

                                     PART I

ITEM 1. FINANCIAL STATEMENTS.

        The Company's unaudited condensed balance sheet as of the end of the
Company's most recent quarter, September 30, 1998 and unaudited condensed
statements of operations for the three month period and statements of cash flow
for the three month period up to the date of the balance sheet and the
comparable period of the preceding fiscal year are attached hereto as pages 5
through 10 and are incorporated herein by this reference.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
        AND RESULTS OF OPERATIONS.

        The following discussion and analysis should be read in conjunction with
the Company's audited financial statements and management's Discussion and
Analysis of Financial Condition and results of Operations included in the
Company's Annual Report on Form 10-KSB, filed with the Securities and Exchange
Commission on August 15, 1998.

        The following discussion includes "forward looking statements" ( "FLS" )
that represent management's assessment of future performance and its goals.
There are no assurances that the forward looking statements will be achieved.

RESULTS OF OPERATIONS

        The three month period ended September 30, 1998 compared to the three
month period ended September 30, 1997.

        The Company realized a net loss of $ 26,096, or $.(01) per share for the
three month period ended September 30, 1998, compared to a net loss of $ 41,065
or $.(01) per share for the corresponding period of the prior fiscal year.
Management attributes these decreased losses to the Company's reduced overhead
and the increase in the gross profit discussed below.

        Net sales of the Company during the three months ended September 30,
1998 decreased $ 22,496 or 24.2% from the corresponding period of the prior
fiscal year. The sales decrease for the three months was attributable to delays
in projects which were sold in October but were originally scheduled to close in
September.

        Gross profit from operations during the three months ended September 30,
1998 increased $ 9,350 or 25.1% from the gross profit from the corresponding
period of the prior fiscal year. Sales for the current quarter included product
lines that carry a higher than normal gross profit.

        General, administrative and selling costs for the three months ended
September 30, 1998 decreased by $ 5,457, and increased as a percentage of sales
from 73.5% of sales to 89.2% of sales in comparison to the corresponding period
of the prior fiscal year. The reduction in overhead for the three months ended
September 30, 1998 indicates management's continued efforts to reduce costs.


                                       3

<PAGE>   4

LIQUIDITY AND CAPITAL RESOURCES

        The three month period ended September 30, 1998 compared to the three
month period ended September 30, 1997.

        The Company had positive cash flow from operating activities for the
three month period ended September 30, 1998 of $ 20,190 compared to a negative
cash flow of $ 26,346 for the three month period ended September 30, 1997. The
positive cash flow compared to the previous period can be attributed to the
issuance of common stock to pay for past legal and administrative services, as
discussed below.

        At September 30, 1998, the Company had net working capital of $ 13,992,
compared to a net negative working capital of $ 37,392 at June 30, 1998. An
increase in working capital of $ 51,784, is primarily the result of the issuance
of common stock as discussed below.

        During the quarter ended September 30, 1998, the Company issued
1,382,740 shares of its common stock, no par value, in exchange for legal
services and administrative service rendered and for future services during the
fiscal year ended June 30, 1999. The shares were valued at nine cents per share.
The Company registered these shares by filing form S-8 with the Securities
Exchange Commission on August 14, 1998.






                                       4


<PAGE>   5

                          SCIENTIFIC NRG, INCORPORATED

                          PART I. FINANCIAL INFORMATION
                     Item 1. Condensed Financial Statements

                            CONDENSED BALANCE SHEETS


<TABLE>
<CAPTION>
                                                          September 30,     June 30,
                                                             1998             1998
 ASSETS                                                   (Unaudited)
<S>                                                      <C>              <C>
 CURRENT ASSETS
   Cash                                                   $    34,557      $    14,367
   Trade receivables, less allowance for
     doubtful accounts at September 30, 1998
     and June 30, 1998 of $ 9,658                              42,987           52,755
   Inventories ( Note 2 )                                      96,264           80,623
   Prepaid expenses                                             3,827            1,708
                                                          -----------      -----------

          Total current assets                                177,635          149,453

 Property and Equipment, net                                    1,664            2,129
                                                          -----------      -----------

          Total assets                                    $   179,299      $   151,582
                                                          ===========      ===========

 LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

 CURRENT LIABILITIES
   Accounts payable                                       $    14,292      $    40,245
   Accrued compensation                                        86,412           45,000
   Other accrued expenses                                      62,940          102,000
                                                          -----------      -----------

         Total current liabilities                            163,644          187,245
                                                          -----------      -----------

 STOCKHOLDERS' EQUITY (DEFICIT)
   Common stock, no par value;
     authorized 40,000,000 shares;
     issued and outstanding:
       September 30, 1998    5,586,163 shares
       June 30, 1998         4,203,423 shares               3,624,321        3,546,707
   Additional paid-in capital                                  11,970           11,970
   Accumulated deficit                                     (3,620,636)      (3,594,340)
                                                          -----------      -----------

         Total  stockholders' equity (deficit)                 15,655          (35,663)

                                                          $   179,299      $   151,582
                                                          ===========      ===========

</TABLE>

                       See accompanying notes to unaudited
                         condensed financial statements



                                       5


<PAGE>   6

                          SCIENTIFIC NRG, INCORPORATED

                        CONDENSED STATEMENT OF OPERATIONS
                                   (UNAUDITED)


<TABLE>
<CAPTION>
                                                  Three Months Ended
                                                     September 30,
                                                   1998          1997
<S>                                            <C>           <C>
 Net sales                                      $  70,652     $  93,148

 Cost of sales                                     33,468        65,314
                                                ---------     ---------

 Gross profit                                      37,184        27,834

 Operating expenses:
   General, administrative,
     and selling costs                             62,995        68,452
   Research and development                           285           447
                                                ---------     ---------

 Loss from operations                             (26,096)      (41,065)

 Other income                                          --            --
 Interest expense                                      --            --
                                                ---------     ---------

 Loss before provision for taxes                  (26,096)      (41,065)

 Provision for taxes                                 (200)         (200)
                                                ---------     ---------

 Net Loss                                       $ (26,296)    $ (41,265)
                                                =========     =========

 Weighted average number
   of shares outstanding                        5,586,163     4,203,423
                                                =========     =========


 Net Loss per common share                      $   (0.01)    $   (0.01)
                                                =========     =========

</TABLE>



                       See accompanying notes to unaudited
                         condensed financial statements




                                       6

<PAGE>   7


                          SCIENTIFIC NRG, INCORPORATED

             CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)
                     Three Months Ended September 30, 1998
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                   Common Stock       Additional
                                                        Paid-In     Accumulated    Stockholders'
                                Shares      Amount      Capital       Equity          Equity
                                                                    (Deficit)        (Deficit)
<S>                          <C>        <C>          <C>          <C>              <C>
Balance, June 30, 1998        4,203,423  $ 3,546,707  $   11,970   $ (3,594,340)     $  (35,663)


Common stock issued in
  connection with legal
  services rendered
  ( Note 3 )                    502,740       45,246          --             --          45,246

Common stock issued in
  connection with services
  rendered under the
  service contract (Note 3)     880,000       79,200          --             --          79,200

Common stock issued in
  connection with services
  not yet rendered by related
  parties  (Note 3)                  --      (46,832)         --             --         (46,832)

Net loss - First Quarter             --           --          --        (26,296)        (26,296)

Balance, September 30, 1998   5,586,163  $ 3,624,321  $   11,970   $ (3,620,636)     $   15,655
                              =========  ===========  ==========   ============      ==========

</TABLE>


                       See accompanying notes to unaudited
                         condensed financial statements





                                       7

<PAGE>   8

                          SCIENTIFIC NRG, INCORPORATED

                        CONDENSED STATEMENTS OF CASH FLOW
                 Three Months Ended September 30, 1998 and 1997
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                     September 30,     September 30,
                                                         1998              1997

<S>                                               <C>                <C>
CASH FLOW FROM OPERATING ACTIVITIES
  Cash received from customers                       $     88,070      $     52,716
  Cash paid to suppliers and employees                    (67,880)          (79,062)
  Interest paid                                                --                --
  Income Taxes Paid                                            --                --
                                                     ------------      ------------

     Net cash provided by (used in) operating
         activities                                        20,190           (26,346)
                                                     ------------      ------------

CASH FLOW USED IN INVESTING ACTIVITIES
  Purchase of equipment and
    leasehold improvements                           $         --      $         --

CASH FLOW FROM FINANCING ACTIVITIES
  Net decrease in line of credit                               --                --
  Proceeds from advances and notes from
    Company's officer and/or director                          --                --
  Principal payments under
    capital lease obligations                                  --                --
  Principal payments on advances                               --                --
  Proceeds from issuance of common stock                       --                --
                                                     ------------      ------------

     Net cash provided by financing activities       $         --      $         --
                                                     ------------      ------------

     Net increase (decrease)  in cash                $     20,190      $    (26,346)

CASH
  Beginning of period                                      14,367            35,300
                                                     ------------      ------------

  Ending of period                                   $     34,557      $      8,954
                                                     ============      ============

</TABLE>





                      See accompanying notes to unaudited
                         condensed financial statements



                                       8


<PAGE>   9

                          SCIENTIFIC NRG, INCORPORATED

                  CONDENSED STATEMENTS OF CASH FLOW (Continued)
                 Three Months Ended September 30, 1998 and 1997
                                   (UNAUDITED)

<TABLE>
<CAPTION>
                                                     September 30,      September 30,
                                                         1998               1997
<S>                                               <C>                 <C>
RECONCILIATION OF NET (LOSS) TO NET CASH
  PROVIDED BY (USED IN) OPERATING ACTIVITIES

  Net (loss)                                         $   (26,296)      $   (41,265)
  Adjustments to reconcile net (loss)
    to net cash provided by (used in) operating
    activities:

    Depreciation and amortization                            465               687
    Compensation expense arising from
      professional services and service
      contracts                                           77,613            18,738

   Change in assets and liabilities:

        Trade receivables                                  9,768           (42,857)
        Inventories                                      (15,639)            5,760
        Prepaid expenses and deposits                     (2,119)             (600)

        Accounts payable, accrued compensation
          and other accrued expenses                     (23,602)           33,191
                                                     -----------       -----------
   Net cash provided by (used in) operating
         activities                                  $    20,190       $   (26,346)
                                                     ===========       ===========
</TABLE>



                      See accompanying notes to unaudited
                         condensed financial statements






                                       9


<PAGE>   10

                          SCIENTIFIC NRG, INCORPORATED

                NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
                                   (UNAUDITED)

                  FOR THE THREE MONTHS ENDED SEPTEMBER 30, 1998

NOTE 1.  BASIS OF PRESENTATION

In the opinion of the Company's management, the accompanying unaudited condensed
financial statements include all adjustments ( consisting of normal accruals )
necessary for the fair presentation of its financial position at September 30,
1998, results of operations for the three months ended September 30, 1998 and
1997 and cashflows for the three months ended September 30, 1998 and 1997.
Although the Company believes that the disclosures in these financial statements
are adequate to make the information presented not misleading, certain
information and disclosures normally included in the financial statements
prepared in accordance with generally accepted accounting principles have been
condensed or omitted.

These financial statements should be read in conjunction with the Company's
audited financial statements included in the Company's Annual Report on
Form10-KSB filed with the Securities and Exchange Commission on August 15, 1998.
Operating results for the three month period ended September 30, 1998 are not
necessarily indicative of the results that may be expected for the Company's
entire year ending June 30, 1999. The Financial Accounting Standards Board has
issued Statement of Financial Accounting Standards 128, "Earnings per Share" (
SFAS 128 ), which was effective for financial statements issued for periods
ending after December 15, 1997. The effect of adopting SFAS 128 has not yet been
determined.

NOTE 2.  INVENTORIES

Inventories are stated at the lower of cost or net realizable value. Cost is
determined under the standard cost method. Costs include materials, direct
labor, and an allocable portion of manufacturing overhead. The Company operates
in an industry in which its products are subject to design changes and
manufactured based upon customer specifications. Accordingly, should design
requirements change significantly or customer orders be canceled, the ultimate
net realizable value of such products could be less than the carrying value of
such amounts. At September 30, 1998, management believes that inventories are
carried at their net realizable value.

NOTE 3.  ISSUANCE OF COMMON STOCK FOR SERVICES

The Company filed form S-8 on August 14, 1998 to register 1,382,740 shares of
common stock to related parties as compensation for legal and administrative
services rendered, and future services to be rendered during the fiscal year
ending June 30, 1999. The shares were valued at nine cents per share.




                                       10



<PAGE>   11

                                     PART II

ITEM 1. LEGAL PROCEEDINGS.

        None.

ITEM 2. CHANGES IN SECURITIES.

        During the quarter ended September 30, 1998, the Company issued
1,382,740 shares of its common stock, no par value, in exchange for legal
services and administrative service rendered and for future services during the
fiscal year ended June 30, 1999. The Company registered these shares by filing
form S-8 with the Securities Exchange Commission on August 14, 1998.


ITEM 3. DEFAULT UPON SENIOR SECURITIES.

        None.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY-HOLDERS.

        A Special Meeting of the Shareholders was held on August 15, 1998 which
resulted in the passing of two resolutions. First, the shareholders approved the
sale of the Company's downlight business which constitutes substantially all of
the Company's assets and operations. Secondly, the shareholders approved a
reverse split of up to one for every ten shares of outstanding common stock. The
second resolution was approved in conjunction with the Company's management
negotiations with non-affiliated companies regarding a potential reverse merger
acquisition (see Note 13 of the Company's Audited financial statements for the
fiscal year ended June 30, 1998 ). Therefore, management anticipates the sale of
substantially all assets of the Company during the fiscal year ending June 30,
1999. Further, in conjunction with this sale, management anticipates a
significant reduction in the number of its employees. The Company will most
likely consist of the Board of Directors and a part-time administrative staff.
This management group will carry out the duty of facilitating the reverse merger
mentioned above (FLS).

ITEM 5. OTHER INFORMATION.

        Subsequent to June 30, 1998, Daniel W. Parke who was the Company's chief
executive officer, resigned from his position as a director and officer of the
Company. This action was a condition subsequent to the acquisition of the
affiliated company, Parke Industries, by Strategic Resource Solutions. Wherein
Mr. Parke agreed to disengage from the Company to avoid any potential conflicts
of interest.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K.


(a)     Documents filed as part of this Form 10-QSB






                                       11


<PAGE>   12

(1) Financial Statements.

Included in Part I of this report:
Condensed Balance Sheets as of September 30, 1998 and June 30, 1998.
Condensed Statements of Operations for the Three Months Ended September 30, 1998
and 1997.
Condensed Statements of Stockholders' Equity (Deficit) for the Three Months
Years Ended September 30, 1998 and 1997.
Condensed Statements of Cash Flows for the Three Months Ended September 30,1998
and 1997.
Notes to Financial Statements.

(2) Financial Data Schedule.

(3) Exhibits.

The following exhibits are incorporated herein by reference from the Company's
initial Form 10 filing on or about November 12, 1986 or in other reports filed
pursuant to the Securities Exchange Act of 1934, as amended.

3.1 Articles of Incorporation as in effect on the date hereof (including
Amendment thereto effective December 28, 1988).
3.3 Bylaws.
4.1 Specimen of Share Certificate 4.6 Incentive Stock Option Plan. 
10.7 Agreement (assigning patent rights).
10.8 Agreement Between Scientific Component Systems, Inc. and NRG, Inc., June
29, 1983.
10.9 Agreement, July, 1983 (assigning patent rights, with Exhibit 10.7 as
exhibit).
10.10 Assignment of Patent Rights from Scientific Component Systems, Inc. to
NRG, Inc., April 20, 1984.
10.11 Assignment of Patent Rights from Rhett McNair and James Helling to NRG,
Inc., April 20, 1984.
10.12 Assignment of Patent Rights from Rhett McNair, James Helling, William R.
Ingles and Gerald L. Fullerton to NRG, Inc., April 20, 1984.
10.13 Agreement Assigning Patent Rights from Scientific Component Systems, Inc.,
to NRG, Inc., April 20, 1984.
10.14 Assignment with Possibility of Reverter of Patent Rights from Rhett McNair
to NRG, Inc., January 21, 1986.
10.20  Form of Warrant Certificate.
10.27  New Lease for Company Headquarters in Tustin, California.
10.28 Royalty Agreement with Rhett McNair.
10.29 Consulting Agreement with MLF & Associates, Inc., April 1, 1990.
10.30 Promissory Note Payable to Oliver Washburn and Extension Thereto.
10.31 Promissory Note Payable to Malcolm Fickel and Extension Thereto.
10.32 Promissory Note Payable to Malcolm Fickel and Extension Thereto.
10.33 Promissory Note Payable to Malcolm Fickel and Extension Thereto.
10.34 Promissory Note Payable to Malcolm Fickel and Extension Thereto.
10.35 Deferred Compensation Agreement Between the Company and Malcolm Fickel.
10.36 Line of Credit Agreement with Bank.
10.37 Promissory Note Payable to Peter C. Kreft.





                                       12


<PAGE>   13

10.38 Stock Purchase Agreement Between the Company and MLF & Associates, Inc.
Retirement Trust, April 30, 1993.
10.39 Stock Purchase Agreement Between the Company and Malcolm L. Fickel, April
30, 1993.
10.40 Stock Purchase Agreement Between the Company and Oliver K. Washburn, April
30, 1993.
10.41 Stock Purchase Agreement Between the Company and Peter C. Kreft, April 30,
1993.
10.42 Stock Purchase Agreement Between the Company and Thomas C. Moceri, April
30, 1993.
10.43 Financing Agreement Between the Company and Pre-Banc Business Credit,
Inc., May 21, 1993.
10.44 Addendum to Consulting Agreement between the Company and Malcolm L.
Fickel, June 30, 1993.
10.45 Leasing Agreement Between the Company and Autocar Leasing Company,
September 9, 1993.
10.46 Stock Warrant Agreement Between the Company and Eddie R. Fischer,
September 9, 1993.
10.47 Note and Revolving Loan Agreement Between the Company and William T.
Moceri, IRA, November 15, 1994.
10.48 Promissory Note Payable to Thomas C. Moceri, Trustee, Thomas C. Moceri
Profit Sharing Plan, September 28, 1994.
10.49 Promissory Note Payable to Oliver Washburn, March 7, 1995.
10.50 Promissory Note Payable to Oliver Washburn, March 7, 1995.
10.51 General Release Agreement Between the Company and Peter Kreft, June 9,
1995.
10.52 Promissory Note Payable to Oliver Washburn, September 14, 1995.
10.53 Promissory Note Payable to Oliver Washburn, November 13, 1995.
10.54 Promissory Note Payable to Oliver Washburn, April 26, 1996.
10.55 Promissory Note Payable to Oliver Washburn, July 18, 1996.
10.56 Workout Agreement dated August 30, 1996.
10.57 Secured Promissory Note to Malcolm L. Fikel, September 11, 1996.
10.58 Secured Promissory Note to Oliver K. Washburn, September 11, 1996.
10.59 Subordinated Cash Flow Promissory Note to Oliver K. Washburn, September
30, 1996.
10.60 Debt For Equity Swap Agreement.
10.61 Administrative Services Agreement.
10.62 Non-Qualified Stock Option Agreement.
10.63 Employment Agreement with Jonathan D. Forgy.
10.64 Employment Agreement with Daniel W. Parke.
28.2 Patent No. 4,520,436 (X-18 Series Downlight).
28.4 Patent No. 4,595,969 (Lamp Mounting Apparatus and Method).
28.5 Patent No. 4,641,228 (Lamp Mounting Apparatus and Method).
28.6 Patent No. 4,700,110 (Lamp Switching).
28.7 Patent No. 4,704,664 (Lamp Apparatus).
28.8 Trademarks Registered (Lightning Bolt Logo, Scientific NRG Component
Systems, SCS, X-18) and Notice of Publication of Trademark, "Switchit".
28.9 Patent No. 4,922,393 (Lamp Apparatus).

(b)     Reports on Form 8-K

There were no reports of Form 8-K filed during the fourth quarter of the year
ended June 30, 1998.



                                       13

<PAGE>   14

                                   SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

Date: November 11, 1998

SCIENTIFIC  NRG, INCORPORATED,
a Minnesota Corporation

By: /s/ Jonathan D. Forgy
Name: Jonathan D. Forgy
Title: President

Pursuant to the requirements of the Securities Exchange Act of 1934, this report
has been signed below by the following persons on behalf of the registrant and
in the capacities and on the dates indicated.

Signatures                              Title                  Date


/s/ Jonathan D. Forgy                  (1) (2)           November 11, 1998
----------------------------
Jonathan D. Forgy


/s/ Oliver K. Washburn                 (1) (3)           November 11, 1998
----------------------------
Oliver K. Washburn


/s/ Richard O. Weed                    (1)               November 11, 1998
----------------------------
Richard O. Weed

(1)  Director of the registrant.
(2)  President of the registrant.
(3)  Treasurer of the registrant.





                                       14


<PAGE>   15


                                 EXHIBIT INDEX


EXHIBIT
NUMBER                   DESCRIPTION
-------                  -----------

 27                 Financial Data Schedule